Pazur J H, Tay M E, Rovnak S E, Pazur B A
Immunol Lett. 1982;5(6):285-91. doi: 10.1016/0165-2478(82)90115-8.
A myeloma protein in ascitic fluid from BALB/c mice bearing W3129 plasma cell tumors was isolated by affinity chromatography. This protein exhibits anti-dextran activity and has been obtained in highly purified form by selective adsorption on isomaltosyl-Sepharose and elution with isomaltose solution. The isomaltosyl-Sepharose was synthesized from maltose, p-aminophenyl glucoside and cyanogen bromide-activated Sepharose by a new procedure utilizing glucosyltransferase and chemical coupling reactions. Results of gel electrophoresis, isoelectrofocusing and agar diffusion experiments showed that the purified myeloma protein consisted of 6 isomeric proteins with each isomer possessing anti-dextran activity. Data from hapten inhibition studies were interpreted to show that the W3129 myeloma protein combines with terminal isomaltosyl units of branched dextrans and oligosaccharides.
通过亲和层析法从携带W3129浆细胞瘤的BALB/c小鼠腹水中分离出一种骨髓瘤蛋白。该蛋白具有抗右旋糖酐活性,通过在异麦芽糖基-琼脂糖凝胶上选择性吸附并用异麦芽糖溶液洗脱,已获得高度纯化的形式。异麦芽糖基-琼脂糖凝胶是由麦芽糖、对氨基苯基葡糖苷和溴化氰活化的琼脂糖,通过利用葡糖基转移酶和化学偶联反应的新方法合成的。凝胶电泳、等电聚焦和琼脂扩散实验结果表明,纯化的骨髓瘤蛋白由6种异构体蛋白组成,每种异构体都具有抗右旋糖酐活性。半抗原抑制研究的数据表明,W3129骨髓瘤蛋白与分支右旋糖酐和寡糖的末端异麦芽糖基单元结合。